Scholarly article on diethyl hexane-1,6-diylbis(nitrosocarbamate) 86178-59-8 from Journal of the American Chemical Society p. 441,443

DOI: 10.1021/ja01631a034

Source and publish data:

Journal of the American Chemical Society p. 441,443 (1954)

Update date:2022-08-03

Topics:

Authors:

Samour Samour

Mason Mason

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01631a034

Full text of DOI:10.1021/ja01631a034

Products guided by the article

Product name:diethyl hexane-1,6-diylbis(nitrosocarbamate)

Cas No:86178-59-8

R&D Labs maybe for 86178-59-8

Geen Chemical Technology Co., Ltd

Contact:86-769-21660847

Address:1408, Yingfeng Commercial Center, Nancheng District
Beijing Tianjia Chemical Science & Technology Co.,Ltd

Contact:86-0550-2392698

Address:No.388, Shiliang Road (East),
Shenzhen ZheYi Chemicals Co.,LTD(Shanghai Branch)

Contact:+86-21-54159691

Address:Room1002,Building No.2, Lane 98 Bixiu Road,Minhang District, Shanghai,China 201100
Skyrun Industrial Co.,Ltd(expird)

website:http://www.chinaskyrun.com

Contact:0086-576-84610586

Address:Chemical Development Zone
Fujian Huitian Biological Pharmacy Co., Ltd.

Contact:0086-598-8300831; 8339920

Address:No.46,Taijiang Road,Sanming City,Fujian,China

Relevant to this article

One catalyst for both enantiomers: Uncovering the inversion of enantioselectivity in cinchona-mediated desymmetrization of glutaric meso-anhydrides

Doi:10.1016/j.tet.2012.07.035
(2012)
ALKALOIDS OF FORMOSAN FISSISTIGMA AND GONIOTHALAMUS SPECIES

Doi:10.1016/S0031-9422(00)82561-3
(1985)
Toward second generation hepatitis C virus NS3 serine protease inhibitors: Discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile

Doi:10.1021/jm801616e
(2009)
A general strategy toward S-linked glycopeptides

Doi:10.1002/anie.200500090
(2005)
Diastereodivergent Control in the Reactions of Allylic and Allenic Organometallic Reagents with Pyruvates

Doi:10.1021/jo00356a026
(1986)
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors

Doi:10.1002/cmdc.201600055
(2016)

Article Doi

DOI: 10.1021/ja01631a034